Nanoparticle encapsulated AChR epitopes CNP-106
Term · Oncology and biomedicine · MLC-T-ONC-015422
A nanoparticle-based formulation consisting of an antigenic acetylcholine receptor (AChR) peptide pool dispersed within a negatively charged polymer matrix of poly(dl-lactide-co-glycolide) (PLGA) particles, with potential immunomodulatory activity. Upon administration, nanoparticle encapsulated AChR epitopes CNP-106 binds to inflammatory cells and delivers multiple AChR epitopes, which initiates tolerogenic immune reprogramming. This may induce and promote antigen-specific tolerance against AChR, which may prevent neuromuscular junction damage and dysfunction that results from autoimmunity targeting AChR.
| Identifier | MLC-T-ONC-015422 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | CNPs encapsulating AChR peptides CNP-106 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015422",
"term": "Nanoparticle encapsulated AChR epitopes CNP-106",
"field": "Oncology and biomedicine",
"definition": "A nanoparticle-based formulation consisting of an antigenic acetylcholine receptor (AChR) peptide pool dispersed within a negatively charged polymer matrix of poly(dl-lactide-co-glycolide) (PLGA) particles, with potential immunomodulatory activity. Upon administration, nanoparticle encapsulated AChR epitopes CNP-106 binds to inflammatory cells and delivers multiple AChR epitopes, which initiates tolerogenic immune reprogramming. This may induce and promote antigen-specific tolerance against AChR, which may prevent neuromuscular junction damage and dysfunction that results from autoimmunity targeting AChR.",
"synonyms": [
"CNPs encapsulating AChR peptides CNP-106"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/nanoparticle-encapsulated-achr-epitopes-cnp-106/"
}
Record 11,574 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.